Education
About Us
Working with TipRanks
Follow Us
Cerus Corp (CERS)
NASDAQ:CERS
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.03Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 01, 2025
|% Change Since: 0.00%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
Cerus Corporation's Q1 2025 earnings call highlighted strong revenue growth, positive customer feedback for new products, and positive financial performance, despite challenges such as EMEA revenue decline and global tariff concerns.Company Guidance
During the Cerus Corporation's Q1 2025 earnings call, the company reiterated its full-year product revenue guidance range of $194 million to $200 million, bolstered by double-digit revenue growth. Cerus highlighted expectations for positive non-GAAP adjusted EBITDA and positive operating cash flows for 2025. The call underscored a 13% year-over-year increase in product revenue, reaching $43.2 million for the quarter, driven by a 22% rise in North American sales. The company also celebrated the earlier-than-anticipated CE Mark for its INT200 illumination device, with plans to submit a PMA to the FDA in 2026. Cerus reported $25.4 million in product gross profit, achieving a 58.8% gross margin, and maintained confidence in meeting growing customer demand, notably with a projected $12 million to $15 million IFC revenue contribution. Despite challenges posed by global tariffs, Cerus expressed optimism in its strategic investments and operational execution to sustain growth.Double-Digit Revenue Growth
Cerus reported product revenue of $43.2 million for Q1 2025, a 13% increase year-over-year, driven by higher North American platelet sales and increasing US demand for IFC.
Positive Market Feedback for New Products
The INT200 LED-based illumination device received CE Mark approval earlier than expected, with initial customer feedback described as very positive.
Increased Operating Cash Flow and Positive EBITDA
Cerus generated positive adjusted EBITDA of $157,000 for Q1 2025 and expects to achieve positive operating cash flow for the full year.
Strong North American Growth
First quarter North American product revenues increased 22% year-over-year, with continued growth expected in both platelet and IFC markets.
---
CERS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CERS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| May 01, 2025 | $1.30 | $1.35 | +3.85% |
| Feb 20, 2025 | $1.74 | $1.65 | -5.17% |
| Oct 30, 2024 | $1.72 | $1.57 | -8.72% |
| Aug 01, 2024 | $2.04 | $2.34 | +14.71% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cerus Corp (CERS) report earnings?
Cerus Corp (CERS) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Cerus Corp (CERS) earnings time?
Cerus Corp (CERS) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CERS EPS forecast?
CERS EPS forecast for the fiscal quarter 2025 (Q2) is -0.03.
---